Europe - BIT:1NOVN - CH0012005267 - Common Stock
Taking everything into account, 1NOVN scores 6 out of 10 in our fundamental rating. 1NOVN was compared to 52 industry peers in the Pharmaceuticals industry. 1NOVN has an excellent profitability rating, but there are some minor concerns on its financial health. 1NOVN is not valued too expensively and it also shows a decent growth rate.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.08% | ||
| ROE | 32.52% | ||
| ROIC | 18.93% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.45% | ||
| PM (TTM) | 24.9% | ||
| GM | 76.12% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | 1.93 | ||
| Altman-Z | 4.03 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.62 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.01 | ||
| Fwd PE | 13.9 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.11 | ||
| EV/EBITDA | 11.48 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.35% |
BIT:1NOVN (10/23/2025, 7:00:00 PM)
113
-4 (-3.42%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.35% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.01 | ||
| Fwd PE | 13.9 | ||
| P/S | 4.63 | ||
| P/FCF | 15.11 | ||
| P/OCF | 12.22 | ||
| P/B | 6.05 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.48 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.08% | ||
| ROE | 32.52% | ||
| ROCE | 25.24% | ||
| ROIC | 18.93% | ||
| ROICexc | 20.86% | ||
| ROICexgc | 123.34% | ||
| OM | 33.45% | ||
| PM (TTM) | 24.9% | ||
| GM | 76.12% | ||
| FCFM | 30.64% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | 1.93 | ||
| Debt/EBITDA | 0.99 | ||
| Cap/Depr | 66.33% | ||
| Cap/Sales | 7.26% | ||
| Interest Coverage | 19.66 | ||
| Cash Conversion | 85.38% | ||
| Profit Quality | 123.09% | ||
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.62 | ||
| Altman-Z | 4.03 |
ChartMill assigns a fundamental rating of 7 / 10 to 1NOVN.MI.
ChartMill assigns a valuation rating of 6 / 10 to NOVARTIS AG-REG (1NOVN.MI). This can be considered as Fairly Valued.
NOVARTIS AG-REG (1NOVN.MI) has a profitability rating of 8 / 10.
The financial health rating of NOVARTIS AG-REG (1NOVN.MI) is 7 / 10.
The Earnings per Share (EPS) of NOVARTIS AG-REG (1NOVN.MI) is expected to grow by 16.18% in the next year.